AEYE
AudioEye, Inc.
AEYE's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over AEYE overall, supported by stronger valuation and lower modeled downside.
AEYE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Strong | |
| Under pressure |
AEYE's cash flow is currently strong, and its revenue is stable, but its profitability and balance sheet are under pressure.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
AEYE PE Valuation
AEYE has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
AEYE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
AEYE has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
AEYE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.24 | — |
| Q3 2026 | -$0.25 | +$0.04 |
| Q2 2026 | -$0.37 | -$0.02 |
| Q1 2026 | -$0.30 | +$0.11 |
| Q4 2025 | -$0.25 | +$0.11 |
| Q3 2025 | -$0.29 | -$0.01 |
| Q2 2025 | -$0.35 | -$0.06 |
| Q1 2025 | -$0.41 | -$0.01 |
| Q4 2024 | -$0.36 | +$0.14 |
AEYE is still losing money, but far less than before: $0.25 per share over the past year, against $1.40 at its worst in mid-2022.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over AEYE on earnings quality, reporting a profit while its opponent remains loss making.
AEYE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11M | +7.2% |
| Q2 2026 | $10.7M | +8.7% |
| Q1 2026 | $10.6M | +8.4% |
| Q4 2025 | $10.5M | +7.9% |
| Q3 2025 | $10.2M | +15% |
| Q2 2025 | $9.9M | +16% |
| Q1 2025 | $9.7M | +20% |
| Q4 2024 | $9.7M | +24% |
AEYE's revenue has grown year over year every quarter since late 2020: $11M last quarter, up 7.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +15 points |
| Q2 2026 | -5.6% | -8 points |
| Q1 2026 | -18% | -8.2 points |
| Q4 2025 | -7.8% | +5.3 points |
| Q3 2025 | -3.1% | +8 points |
| Q2 2025 | 2.5% | +8.3 points |
| Q1 2025 | -9.7% | -1.9 points |
| Q4 2024 | -13% | -6.8 points |
AEYE's operating margin was 11% last quarter, up 15 points from the same quarter a year ago, near the top of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over AEYE on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over AEYE on profitability, with a higher operating margin.
AEYE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.7M | +67% |
| Q2 2026 | $1M | -15% |
| Q1 2026 | $1.2M | +$1.3M |
| Q4 2025 | $2.5M | +377% |
| Q3 2025 | $1M | -32% |
| Q2 2025 | $1.2M | +205% |
| Q1 2025 | -$47K | -132% |
| Q4 2024 | $525K | -35% |
AEYE generated $7M in free cash flow over the past year, up 139% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over AEYE on cash flow, with more consistent year-over-year improvement.
AEYE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +482K shares |
| 1 year | +4.5% | +557K shares |
| 3 years | +11% | +1.2M shares |
| 5 years | +45% | +4M shares |
AEYE has 13M diluted shares, up 4.5% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $475,000 |
| Q4 2025 | $989,000 |
| Q3 2025 | $1.8M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $330,000 |
AEYE spent $1M buying back its own shares over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over AEYE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
AEYE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.7x | Elevated |
| Q2 2026 | 29.1x | High |
| Q1 2026 | 7.8x | High |
| Q4 2025 | 4.4x | High |
| Q3 2025 | 7.9x | High |
| Q2 2025 | 94.8x | High |
AEYE's net debt is about 3.7 years of its operating earnings (EBITDA), down from 7.9 years a year ago.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over AEYE on leverage, with a lower net debt burden relative to earnings.
AEYE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.2 | Overbought |
| Stochastic | 84.2 | Overbought |
AEYE's weekly RSI is 74 (overbought) and its Stochastic is 84 (overbought).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
AEYE PE vs Technology Sector
AEYE has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
AEYE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.39 | 52% above |
| 20 week MA | $7.90 | 81% above |
| 50 week MA | $7.89 | 81% above |
| 100 week MA | $10.6 | 35% above |
| 200 week MA | $11.0 | 30% above |
AEYE has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
AEYE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.75 | $26.2 | +452% |
| 2021 | $26.2 | $7.00 | -73% |
| 2022 | $7.00 | $3.85 | -45% |
| 2023 | $3.85 | $5.42 | +41% |
| 2024 | $5.42 | $16.1 | +197% |
| 2025 | $16.1 | $10.7 | -34% |
| 2026 YTD | $10.7 | $14.3 | +34% |
AEYE has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.